• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

除了肾功能丧失:常染色体显性遗传性多囊肾病的患者护理。

Beyond Loss of Kidney Function: Patient Care in Autosomal Dominant Polycystic Kidney Disease.

机构信息

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.

Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut.

出版信息

Kidney360. 2023 Dec 1;4(12):1806-1815. doi: 10.34067/KID.0000000000000296. Epub 2023 Nov 27.

DOI:10.34067/KID.0000000000000296
PMID:38010035
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10758524/
Abstract

Patients with autosomal dominant polycystic kidney disease benefit from specialized care over their lifetimes, starting with diagnosis of the condition with ongoing discussion of both the renal course and extra-renal issues. Both renal and extra-renal issues may continue to cause major morbidity even after successful kidney transplant or initiation of RRT, and extra-renal disease aspects should always be considered as part of routine management. In this review, we will focus on updates in pain/depression screening, cardiac manifestations, liver and pancreatic cysts, kidney stone management, and genetic counseling. In some instances, we have shared our current clinical practice rather than an evidence-based guideline. We anticipate more standardization of care after the release of the Kidney Disease Improving Global Outcomes guidelines for management in autosomal dominant polycystic kidney disease later this year.

摘要

常染色体显性遗传性多囊肾病患者受益于终身的专业护理,从诊断开始,持续讨论肾脏病程和肾脏以外的问题。即使在成功进行肾移植或开始肾脏替代治疗后,肾脏和肾脏以外的问题仍可能导致严重的发病率,并且应始终将肾脏以外疾病的各个方面视为常规管理的一部分。在本次综述中,我们将重点介绍疼痛/抑郁筛查、心脏表现、肝脏和胰腺囊肿、肾结石管理以及遗传咨询方面的最新进展。在某些情况下,我们分享的是目前的临床实践,而不是循证指南。我们预计今年晚些时候,肾脏病预后质量倡议发布常染色体显性遗传性多囊肾病管理指南后,护理将更加标准化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b150/10758524/00ad03fe59d6/kidney360-4-1806-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b150/10758524/c640b53dbf2b/kidney360-4-1806-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b150/10758524/00ad03fe59d6/kidney360-4-1806-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b150/10758524/c640b53dbf2b/kidney360-4-1806-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b150/10758524/00ad03fe59d6/kidney360-4-1806-g002.jpg

相似文献

1
Beyond Loss of Kidney Function: Patient Care in Autosomal Dominant Polycystic Kidney Disease.除了肾功能丧失:常染色体显性遗传性多囊肾病的患者护理。
Kidney360. 2023 Dec 1;4(12):1806-1815. doi: 10.34067/KID.0000000000000296. Epub 2023 Nov 27.
2
Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management.常染色体显性多囊肾病(ADPKD)的肾外表现:常规筛查与管理的考量
Nephrol Dial Transplant. 2014 Feb;29(2):247-54. doi: 10.1093/ndt/gft437. Epub 2013 Nov 8.
3
Spanish guidelines for the management of autosomal dominant polycystic kidney disease.常染色体显性多囊肾病管理的西班牙指南。
Nephrol Dial Transplant. 2014 Sep;29 Suppl 4:iv95-105. doi: 10.1093/ndt/gfu186.
4
ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.2001 - 2010年美国常染色体显性多囊肾病导致的终末期肾病
Am J Kidney Dis. 2014 Oct;64(4):592-9. doi: 10.1053/j.ajkd.2014.05.020. Epub 2014 Aug 16.
5
Recent advances in the clinical management of autosomal dominant polycystic kidney disease.常染色体显性多囊肾病临床管理的最新进展
F1000Res. 2019 Jan 29;8. doi: 10.12688/f1000research.17109.1. eCollection 2019.
6
Outcome of Kidney Transplant in Patients with Polycystic Kidney Disease: A Single-Center Study in Tunisia.多囊肾病患者肾移植的结局:突尼斯的一项单中心研究
Exp Clin Transplant. 2017 Feb;15(Suppl 1):196-199. doi: 10.6002/ect.mesot2016.P78.
7
Autosomal dominant polycystic kidney disease.常染色体显性多囊肾病
Am Fam Physician. 1996 Feb 15;53(3):925-31.
8
Identifying and integrating consumer perspectives in clinical practice guidelines on autosomal-dominant polycystic kidney disease.在常染色体显性多囊肾病临床实践指南中识别并整合患者观点。
Nephrology (Carlton). 2016 Feb;21(2):122-32. doi: 10.1111/nep.12579.
9
Recognition and Management of a Less Common Cause of Chronic Kidney Disease: Autosomal Dominant Polycystic Kidney Disease.慢性肾脏病一种较罕见病因的识别与管理:常染色体显性多囊肾病
J Fam Pract. 2020 Sep;69(7 Suppl):S57-S62.
10
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.常染色体显性多囊肾病(ADPKD):来自改善全球肾脏病预后组织(KDIGO)争议会议的执行摘要
Kidney Int. 2015 Jul;88(1):17-27. doi: 10.1038/ki.2015.59. Epub 2015 Mar 18.

引用本文的文献

1
Multifaceted roles of Epac signaling in renal functions.Epac信号通路在肾功能中的多方面作用。
Biochem J. 2025 May 14;482(10):553-68. doi: 10.1042/BCJ20253103.
2
Overview of ADPKD in Pregnancy.妊娠期常染色体显性多囊肾病概述
Kidney Int Rep. 2025 Jan 2;10(4):1011-1019. doi: 10.1016/j.ekir.2024.12.035. eCollection 2025 Apr.
3
Mission and Future Plans for the Autosomal Dominant Polycystic Kidney Disease Centers of Excellence Program.常染色体显性多囊肾病卓越中心项目的使命与未来计划。
Kidney360. 2025 Jan 1;6(1):159-166. doi: 10.34067/KID.0000000652. Epub 2024 Nov 19.
4
Determinants of Disease Progression in Autosomal Dominant Polycystic Kidney Disease.常染色体显性多囊肾病疾病进展的决定因素
J Pers Med. 2024 Sep 2;14(9):936. doi: 10.3390/jpm14090936.
5
Mental Health and Autosomal Dominant Polycystic Kidney Disease: A Narrative Review.精神健康与常染色体显性遗传性多囊肾病:叙述性综述。
Kidney360. 2024 Aug 1;5(8):1200-1206. doi: 10.34067/KID.0000000000000504. Epub 2024 Jul 8.
6
A Primer for Utilizing Deep Learning and Abdominal MRI Imaging Features to Monitor Autosomal Dominant Polycystic Kidney Disease Progression.利用深度学习和腹部MRI成像特征监测常染色体显性多囊肾病进展的入门指南。
Biomedicines. 2024 May 20;12(5):1133. doi: 10.3390/biomedicines12051133.
7
Autosomal Dominant Polycystic Kidney Disease: Extrarenal Involvement.常染色体显性遗传性多囊肾病:肾外表现。
Int J Mol Sci. 2024 Feb 22;25(5):2554. doi: 10.3390/ijms25052554.